Literature DB >> 11438018

Epidemiological survey of chronic obstructive pulmonary disease and alpha-1 antitrypsin deficiency in Korea.

Y S Shim1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11438018     DOI： 10.1046/j.1440-1843.2001.00305.x

Source DB:  PubMed          Journal:  Respirology        ISSN： 1323-7799            Impact factor:   6.424


× No keyword cloud information.
  6 in total

Review 1.  Chronic obstructive pulmonary disease in alpha1-antitrypsin PI MZ heterozygotes: a meta-analysis.

Authors:  C P Hersh; M Dahl; N P Ly; C S Berkey; B G Nordestgaard; E K Silverman
Journal:  Thorax       Date:  2004-10       Impact factor: 9.139

Review 2.  Updates on the COPD gene list.

Authors:  Yohan Bossé
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2012-09-18

3.  Alpha-1 antitrypsin gene polymorphism in Chronic Obstructive Pulmonary Disease (COPD).

Authors:  Sabri Denden; Amel Haj Khelil; Jalel Knani; Ramzi Lakhdar; Pascale Perrin; Gérard Lefranc; Jemni Ben Chibani
Journal:  Genet Mol Biol       Date:  2010-03-01       Impact factor: 1.771

4.  Alpha-1 antitrypsin deficiency in Iranian patients with chronic obstructive pulmonary disease.

Authors:  Bita Geramizadeh; Zahra Jowkar; Leila Karami; Masoum Masoumpour; Samrad Mehrabi; Mohammad-Ali Ghayoumi
Journal:  Iran Red Crescent Med J       Date:  2013-11-05       Impact factor: 0.611

5.  Case-finding for alpha1-antitrypsin deficiency in Kazakh patients with COPD.

Authors:  Angelo Corsico; Ilaria Ferrarotti; Ardak Zhumagaliyeva; Stefania Ottaviani; Timm Greulich; Marina Gorrini; Claus Vogelmeier; Ludmila Karazhanova; Gulmira Nurgazina; Annalisa DeSilvestri; Victor Kotke; Valentina Barzon; Michele Zorzetto
Journal:  Multidiscip Respir Med       Date:  2017-10-25

6.  Unmet needs of patients with chronic obstructive pulmonary disease (COPD): a qualitative study on patients and doctors.

Authors:  Stalia S L Wong; Nurdiana Abdullah; Adina Abdullah; Su-May Liew; Siew-Mooi Ching; Ee-Ming Khoo; Moyez Jiwa; Yook-Chin Chia
Journal:  BMC Fam Pract       Date:  2014-04-16       Impact factor: 2.497
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.